Ortho-McNeil

Ceftobiprole, a new anti-MRSA broad-spectrum antibiotic, receives approval by Swissmedic

Basel, Switzerland, November 13, 2008 - Basilea Pharmaceutica Ltd. announces that ceftobiprole (Zevtera(TM)), the first-in-class anti-MRSA broad-spectrum cephalosporin, has obtained regulatory appr.. - Read more

Rivaroxaban Phase II Dose-Ranging Study Demonstrates Encouraging Response Rates In Treatment Of...

Findings from the Phase II ATLAS ACS TIMI 46 study of rivaroxaban, a novel, investigational, oral anticoagulant, were presented today as a late-breaking clinical trial at the American Heart Association's Scientific Sessions...

Winners Chosen for National Expressions of Courage Art Contest

In celebration of National Epilepsy Awareness Month, Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, and the Epilepsy Foundation today announced the winners of the 2008 Expressions of Courage...

Alkermes Announces Second Quarter Fiscal 2009 Results (Business Wire)

CAMBRIDGE, Mass.----Alkermes, Inc. today announced financial results for its second quarter of fiscal 2009. Financial highlights for the quarter ended September 30, 2008 include: A profitable quarter on a GAAP basis, with net...

India's Torrent Pharma gets US nod for risperidone

MUMBAI, Nov 6 (Reuters) - India's Torrent Pharmaceuticals Ltd's (TORP.BO: ) generic, risperidone, in tablet forms of various strengths, has got the approval of the U.S. Food and Drug Administration, as per the regulator's...

Torrent Pharma gets US nod for Risperidone

Torrent Pharmaceuticals generic, Risperidone, in tablet forms of various strengths, has got the approval of the US Food and Drug Administration, as per the regulator's website. The drug is the generic version of...

Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective...

First Clinical Study of Paliperidone ER in this Under-Studied Condition SAN DIEGO, Nov. 1, 2008 /PRNewswire via COMTEX News Network/ -- Patients with schizoaffective disorder receiving paliperidone extended release tablets...

Treatment With Paliperidone ER Significantly Improves Symptoms Of Schizoaffective Disorder

Patients with schizoaffective disorder receiving paliperidone extended release tablets (paliperidone ER) for six weeks showed a significant improvement in their symptoms, according to a new study presented today at the U.S....

Treatment With Paliperidone ER Improves Symptoms Of Schizoaffective Disorder

Patients with schizoaffective disorder receiving paliperidone extended release tablets (paliperidone ER) for six weeks showed a significant improvement in their symptoms, according to a new study presented today at the U.S....

Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results (PR Newswire)

Thursday October 30, 4:03 pm ET SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- News ) today reported financial results for the third quarter ended September 30, 2008. Total revenues in the third quarter of 2008 were $1.9 million,...

1 2 next